Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders (vol 55, pg 330, 2018)

被引：0
|
作者：
Kocaman, Gulsen [1 ]
Kahraman, Nese [2 ]
Gurkan Koseoglu, Banu [2 ]
Bilgic, Basar [3 ]
Matur, Zeliha [4 ]
Ertas, Mustafa [5 ]
Gulsen, Yesim [3 ]
Baykan, Betul [3 ]
机构：
[1] Bezmialem Vakif Univ, Dept Neurol, Fac Med, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Dent, Dept Maxillofacial Surg, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey
[4] Istanbul Bilim Univ, Dept Neurol, Fac Med, Istanbul, Turkey
[5] Private Off, Neurol, Istanbul, Turkey
来源：
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 2019年 / 56卷 / 01期
关键词：
D O I：
10.29399/npa.23634
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [11] Efficacy of fremanezumab in patients with chronic migraine with or without concomitant use of preventive medication (vol 19, pg P8, 2018)
    Goadsby, Peter J.
    Dodick, David W.
    Silberstein, Stephen D.
    Yeung, Paul P.
    Blankenbiller, Tricia
    Ning, Xiaoping
    Yang, Ronghua
    Ma, Yuju
    Aycardi, Ernesto
    Bigal, Marcelo E.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [12] Optimal response to onabotulinumtoxina in chronic migraine: evaluation in a series of 124 patients
    Garcia-Azorin, D.
    Ruiz, M.
    Pedraza, M. I.
    Guerrero, Al
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [13] Treatment With OnabotulinumtoxinA vs Erenumab for Patients With Acquired/posttraumatic Chronic Migraine
    Rothrock, J. F.
    Tinsley, A.
    Koutsandreas, A. K.
    HEADACHE, 2020, 60 : 145 - 145
  • [14] Cortical excitability in chronic migraine patients after OnabotulinumtoxinA preventive treatment
    Shevchenko, Vladlena
    Artemenko, Ada
    Bzhiljanski, Mikhail
    Bushkov, Fedor
    Yahno, Nikolay
    Kurenkov, Alexey
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [15] Migraine, temporomandibular joint disorders and mandibular loci (vol 74, pg 814, 1995)
    Fartash, L
    Clifford, TJ
    Lamey, PJ
    JOURNAL OF DENTAL RESEARCH, 1996, 75 (05) : 1203 - 1203
  • [16] Effectiveness and safety of OnabotulinumtoxinA in the treatment of chronic migraine in patients older than 65
    Castanon, M.
    Ameijide, E.
    Sanchez, J. M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [17] OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
    Isabel Pedraza, Maria
    de la Cruz, Carolina
    Ruiz, Marina
    Lopez-Mesonero, Luis
    Martinez, Elena
    de Lera, Mercedes
    Luis Guerrero, Angel
    SPRINGERPLUS, 2015, 4
  • [18] Amitriptyline treatment of chronic pain in patients with temporomandibular disorders
    Plesh, O
    Curtis, D
    Levine, J
    McCall, WD
    JOURNAL OF ORAL REHABILITATION, 2000, 27 (10) : 834 - 841
  • [19] OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study (vol 49, pg 540, 2022)
    Boudreau, Guy
    Finkelstein, Ian
    Graboski, Corrie
    Ong, May
    Christie, Suzanne
    Sommer, Katherine
    Bhogal, Meetu
    Davidovic, Goran
    Becker, Werner J.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024, 51 (01) : 149 - 149
  • [20] Management and treatment challenges for patients with chronic migraine, application of OnabotulinumtoxinA: early results of 70 patients
    Senturk, A.
    Demiryurek, B. E.
    Uzun, G. Altiokka
    Erdogan, S.
    Omerhoca, S.
    Icen, N. Kale
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 390 - 390
12345